BCYC
Bicycle Therapeutics Ltd
3.80$
+2.1%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -19.2% | -887.0% | -362.7% | -477.6% | -1,488.5% | -253.4% | -869.0% | -2,492.7% | -606.6% | -39.7% | -7,432.4% | -7,886.5% | -336.1% | |
| 31.6% | 31.0% | 8.5% | 17.5% | 81.1% | 45.5% | 16.4% | 58.1% | 15.0% | -10.6% | 127.3% | 169.6% | -1.9% | |
| 138.8% | 146.5% | 47.5% | 99.0% | 343.9% | 278.7% | 96.3% | 323.1% | 74.7% | -58.0% | 781.3% | 1,018.1% | -9.3% | |
| 276.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 605.2% | -152.5% | -279.3% | -168.5% | 23.6% | 969.0% | -357.6% | -158.7% | -192.2% | 131.1% | -1,456.4% | -1,421.6% | 30.1% | |
| 9.4% | 1.0% | 0.1% | 4.5% | 16.3% | 9.9% | 6.1% | 17.1% | 5.7% | 3.7% | 80.4% | 42.1% | 5.6% | |
| -9.4% | -1.0% | -0.1% | -4.5% | -16.3% | -9.9% | -6.1% | -17.1% | -5.7% | -1.2% | -80.4% | -42.1% | -3.6% | |
| – | – | – | – | -1,190.7% | -1.1% | -0.4% | -1.6% | -0.3% | -0.1% | -7.4% | -8.1% | -0.3% | |
| 4,384.0% | 7.2% | 9.6% | 5,873.1% | -1,193.2% | 5.5% | -0.4% | -1.5% | -0.3% | 0.0% | -6.1% | -7.9% | -0.2% | |
| 4,338.6% | -856.6% | -355.5% | 5,388.0% | -2,634.6% | -305.9% | -867.5% | -2,449.4% | -623.2% | -41.0% | -7,738.0% | -7,944.4% | -345.4% | |
| -28.5% | -888.0% | -362.7% | -482.0% | -1,504.7% | -263.3% | -875.1% | -2,509.7% | -612.3% | -35.9% | -7,512.7% | -7,928.6% | -335.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.